ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Amphastar Receives FDA Approval for Dextrose Injection americanpharmaceuticalreview
March 30, 2021Amphastar Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approved the Company’s Abbreviated New Drug Application (ANDA) for Dextrose injection 50% in the 50 mL Luer-Jet? Prefilled Syringe System.
Pharma Sources Insight January 2025
